Vetoquinol acquires Canadian rights to Profender®

"The acquisition of this strong brand for the Canadian market confirms our ambition to become a major player in the parasiticide segment" - Matthieu Frenchin, CEO of Vetoquinol.
Animal health company Vetoquinol has announced the acquisition of the Canadian rights to the Profender® product family from Elanco Animal Health.
The move follows the firm's acquisition of Profender® and Drontal® product families, in relation to Elanco's 2020 acquisition of Bayer Animal Health. In January 2021, Vetoquinol also acquired the Profender® and Drontal® product families in Australia.
Commenting on the acquisition, Matthieu Frechin, CEO of Vetoquinol, said: "We are very pleased to acquire Profender® for the Canadian market, one of our prominent strategic countries.
“The acquisition of this strong brand for the Canadian market confirms our ambition to become a major player in the parasiticide segment. Adding this essential to our product portfolio in Canada will strengthen our market share in the pet segment in this strategic country.”
The Profender® family of products encompasses a range of spot-on solutions for cats.



Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.